MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Chan, 2005, Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy, Int J Radiat Oncol Biol Phys, 61, 665, 10.1016/j.ijrobp.2004.06.206 Duldulao, 2013, Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer, Dis Colon Rectum, 56, 142, 10.1097/DCR.0b013e31827541e2 Glynne-Jones, 2008, Complete clinical response after preoperative chemoradiation in rectal cancer: is a "wait and see" policy justified?, Dis Colon Rectum, 51, 10, 10.1007/s10350-007-9080-8 Maas, 2010, Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data, Lancet Oncol, 11, 835, 10.1016/S1470-2045(10)70172-8 Park, 2014, Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapy, World J Gastroenterol, 20, 2023, 10.3748/wjg.v20.i8.2023 Habr-Gama, 2004, Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results, Ann Surg, 240, 711, 10.1097/01.sla.0000141194.27992.32 Marijnen, 2015, Organ preservation in rectal cancer: have all questions been answered?, Lancet Oncol, 16, e13, 10.1016/S1470-2045(14)70398-5 Horvat, 2019, MRI of rectal cancer: tumor staging, imaging techniques, and management, Radiographics, 39, 367, 10.1148/rg.2019180114 Delli Pizzi, 2018, Rectal cancer MRI: protocols, signs and future perspectives radiologists should consider in everyday clinical practice, Insights Imaging, 9, 405, 10.1007/s13244-018-0606-5 Patel, 2011, Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience, J Clin Oncol, 29, 3753, 10.1200/JCO.2011.34.9068 Kang, 2010, Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response, Int J Radiat Oncol Biol Phys, 76, 1018, 10.1016/j.ijrobp.2009.03.066 Curvo-Semedo, 2011, Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy–conventional MR volumetry versus diffusion-weighted MR imaging, Radiology, 260, 734, 10.1148/radiol.11102467 Delli Pizzi, 2018, Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy, Abdom Radiol (NY), 43, 2221, 10.1007/s00261-018-1457-8 Rosa, 2019, Reproducibility of rectal tumor volume delineation using diffusion-weighted MRI: Agreement on volumes between observers, Cancer Radiother, 23, 216, 10.1016/j.canrad.2018.10.004 Lambregts, 2020, Long-term imaging characteristics of clinical complete responders during watch-and-wait for rectal cancer-an evaluation of over 1500 MRIs, Eur Radiol, 30, 272, 10.1007/s00330-019-06396-1 Haak, 2020, Selection of patients for organ preservation after chemoradiotherapy: mri identifies poor responders who can go straight to surgery, Ann Surg Oncol, 27, 2732, 10.1245/s10434-020-08334-8 Delli Pizzi, 2019, Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancer, Abdom Radiol (NY), 44, 3595, 10.1007/s00261-019-02177-y Jang, 2018, Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer, Br J Surg, 105, 1671, 10.1002/bjs.10898 Sclafani, 2017, Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer, Br J Cancer, 117, 1478, 10.1038/bjc.2017.320 Aker, 2018, Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment, Abdom Radiol (NY), 43, 3213, 10.1007/s00261-018-1627-8 Siddiqui, 2016, Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales, World J Gastroenterol, 22, 8414, 10.3748/wjg.v22.i37.8414 Bhoday, 2016, Magnetic resonance tumor regression grade and residual mucosal abnormality as predictors for pathological complete response in rectal cancer postneoadjuvant chemoradiotherapy, Dis Colon Rectum, 59, 925, 10.1097/DCR.0000000000000667 Yip, 2016, Applications and limitations of radiomics, Phys Med Biol, 61, R150, 10.1088/0031-9155/61/13/R150 Liu, 2017, Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer, Clin Cancer Res, 23, 7253, 10.1158/1078-0432.CCR-17-1038 Bae, 2018, Radiomic MRI phenotyping of glioblastoma: improving survival prediction, Radiology, 289, 797, 10.1148/radiol.2018180200 Crombé, 2019, T(2) -based MRI Delta-radiomics improve response prediction in soft-tissue sarcomas treated by neoadjuvant chemotherapy, J Magn Reson Imaging, 50, 497, 10.1002/jmri.26589 Chang, 2019, An investigation of machine learning methods in delta-radiomics feature analysis, PLoS One, 14, 10.1371/journal.pone.0226348 Blazic, 2017, Quantitative assessment of rectal cancer response to neoadjuvant combined chemotherapy and radiation therapy: comparison of three methods of positioning region of interest for ADC measurements at diffusion-weighted MR imaging, Radiology, 282, 418, 10.1148/radiol.2016151908 Kim, 2018, T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer, Eur Radiol, 28, 5231, 10.1007/s00330-018-5520-1 van den Broek, 2017, Accuracy of MRI in restaging locally advanced rectal cancer after preoperative chemoradiation, Dis Colon Rectum, 60, 274, 10.1097/DCR.0000000000000743 Fayaz, 2016, Significance of magnetic resonance imaging-assessed tumor response for locally advanced rectal cancer treated with preoperative long-course chemoradiation, J Glob Oncol, 2, 216, 10.1200/JGO.2015.001479 Horvat, 2018, MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy, Radiology, 287, 833, 10.1148/radiol.2018172300 Nie, 2016, Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI, Clin Cancer Res, 22, 5256, 10.1158/1078-0432.CCR-15-2997 Petkovska, 2020, Clinical utility of radiomics at baseline rectal MRI to predict complete response of rectal cancer after chemoradiation therapy, Abdom Radiol (NY), 10.1007/s00261-020-02502-w O'Connor, 2015, Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome, Clin Cancer Res, 21, 249, 10.1158/1078-0432.CCR-14-0990 Vogelstein, 2013, Cancer genome landscapes, Science, 339, 1546, 10.1126/science.1235122 Lin, 2020, A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma, Cancer Imaging, 20, 7, 10.1186/s40644-019-0283-8 Li, 2019, Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer, Cancer Med, 8, 7244, 10.1002/cam4.2636 Wan, 2019, Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer, Abdom Radiol (NY), 44, 2978, 10.1007/s00261-019-02129-6 Liu, 2019, MRI radiomics analysis for predicting preoperative synchronous distant metastasis in patients with rectal cancer, Eur Radiol, 29, 4418, 10.1007/s00330-018-5802-7